Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study

被引：0
|
作者：
Mathilde Fraty
Gilberto Velho
Elise Gand
Fréderic Fumeron
Stéphanie Ragot
Philippe Sosner
Kamel Mohammedi
Barnabas Gellen
Pierre-Jean Saulnier
Jean-Michel Halimi
David Montaigne
Grégory Ducrocq
Michaela Rehman
Michel Marre
Ronan Roussel
Samy Hadjadj
机构：
[1] CHU de Poitiers,Centre d’Investigation Clinique
[2] CHU de Poitiers,Service d’Endocrinologie
[3] Centre de Recherche des Cordeliers,Diabétologie
[4] Inserm UMR_S 1138,Pole DUNE (Digestif, Urologie, Néphrologie, Endocrinologie)
[5] CHU de Poitiers,Laboratoire MOVE (EA 6314), Faculté des Sciences du Sport
[6] UFR de Médecine,Service de Cardiologie
[7] Université Paris Diderot,Service Néphrologie, Dialyse et Transplantation
[8] Sorbonne Paris Cité,Clinique de Physiologie et Département d’Échocardiographie
[9] UFR de Médecine et Pharmacie,Service de Cardiologie
[10] Université de Poitiers,undefined
[11] CIC 1402,undefined
[12] Inserm Poitiers,undefined
[13] Centre médico-sportif MON STADE,undefined
[14] Centre de Diagnostic et de Thérapeutique,undefined
[15] AP-HP Hôpital Universitaire Hôtel-Dieu,undefined
[16] Université de Poitiers,undefined
[17] Service Endocrinologie,undefined
[18] Diabétologie,undefined
[19] Nutrition,undefined
[20] Hôpital Haut Lévêque,undefined
[21] CHU de Bordeaux,undefined
[22] Polyclinique de Poitiers,undefined
[23] CHU de Tours,undefined
[24] Inserm CIC0202,undefined
[25] CHRU Lille,undefined
[26] Inserm U1011,undefined
[27] EGID,undefined
[28] Institut Pasteur de Lille,undefined
[29] Université de Lille,undefined
[30] Service de Cardiologie,undefined
[31] AP-HP,undefined
[32] Hôpital Bichat Claude Bernard,undefined
[33] CHU de Poitiers,undefined
[34] Service de Diabétologie,undefined
[35] Endocrinologie et Nutrition,undefined
[36] DHU FIRE,undefined
[37] AP-HP,undefined
[38] Hôpital Bichat Claude Bernard,undefined
来源：
Diabetologia | 2018年 / 61卷
关键词：
Adrenomedullin; Biomarkers; BNP; Heart failure; NT-proBNP; Prognosis; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2643 / 2653
页数：10
相关论文
共 50 条
  • [1] Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study
    Fraty, Mathilde
    Velho, Gilberto
    Gand, Elise
    Fumeron, Frederic
    Ragot, Stephanie
    Sosner, Philippe
    Mohammedi, Kamel
    Gellen, Barnabas
    Saulnier, Pierre-Jean
    Halimi, Jean-Michel
    Montaigne, David
    Ducrocq, Gregory
    Rehman, Michaela
    Marre, Michel
    Roussel, Ronan
    Hadjadj, Samy
    DIABETOLOGIA, 2018, 61 (12) : 2643 - 2653
  • [2] A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
    Linssen, G. C. M.
    Jaarsma, T.
    Hillege, H. L.
    Voors, A. A.
    van Veldhuisen, D. J.
    NETHERLANDS HEART JOURNAL, 2018, 26 (10) : 486 - 492
  • [3] A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
    G. C. M. Linssen
    T. Jaarsma
    H. L. Hillege
    A. A. Voors
    D. J. van Veldhuisen
    Netherlands Heart Journal, 2018, 26 : 486 - 492
  • [4] Prognostic value of RDW alone and in combination with NT-proBNP in patients with heart failure
    Liang, Lin
    Huang, Liyan
    Zhao, Xuemei
    Zhao, Lang
    Tian, Pengchao
    Huang, Boping
    Feng, Jiayu
    Zhang, Jian
    Zhang, Yuhui
    CLINICAL CARDIOLOGY, 2022, 45 (07) : 802 - 813
  • [5] Prognostic value of the combination of uric acid and NT-proBNP in patients with chronic heart failure
    Oztekin, Gulsum Meral Yilmaz
    Genc, Ahmet
    Cagirci, Goksel
    Arslan, Sakir
    HELLENIC JOURNAL OF CARDIOLOGY, 2022, 65 : 35 - 41
  • [6] Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP
    Bayes-Genis, Antoni
    Barallat, Jaume
    Galan, Amparo
    de Antonio, Marta
    Domingo, Mar
    Zamora, Elisabet
    Gastelurrutia, Paloma
    Vila, Joan
    Penafiel, Judith
    Galvez-Monton, Carolina
    Lupon, Josep
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (12): : 1075 - 1084
  • [7] The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP
    Leto, Laura
    Testa, Marzia
    Feola, Mauro
    MINERVA CARDIOANGIOLOGICA, 2016, 64 (02): : 157 - 164
  • [8] Prognostic Implications of Chronic Heart Failure and Utility of NT-proBNP Levels in Heart Failure Patients with SARS-CoV-2 Infection
    Belarte-Tornero, Laia C.
    Valdivielso-More, Sandra
    Vicente Elcano, Miren
    Sole-Gonzalez, Eduard
    Ruiz-Bustillo, Sonia
    Calvo-Fernandez, Alicia
    Subinara, Isaac
    Cabero, Paula
    Soler, Cristina
    Cubero-Gallego, Hector
    Vaquerizo, Beatriz
    Farre, Nuria
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (02) : 1 - 14
  • [9] Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients
    Cortes, Raquel
    Portoles, Manuel
    Salvador, Antonio
    Bertomeu, Vicente
    Garcia de Burgos, Fernando
    Martinez-Dolz, Luis
    Rosello Lleti, Esther
    Climent, Vicente
    Jordan, Alejandro
    Paya, Rafael
    Sogorb, Francisco
    Rivera, Miguel
    EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (06) : 621 - 627
  • [10] Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study
    Gaborit, Freja Stoltze
    Kistorp, Caroline
    Kumler, Thomas
    Hassager, Christian
    Tonder, Niels
    Iversen, Kasper
    Hansen, Pernille Mork
    Kamstrup, Pia Rorbaek
    Faber, Jens
    Kober, Lars
    Schou, Morten
    BIOMARKERS, 2020, 25 (03) : 248 - 259
12345